These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30774558)

  • 21. Hyaluronic acid conjugated superparamagnetic iron oxide nanoparticle for cancer diagnosis and hyperthermia therapy.
    Thomas RG; Moon MJ; Lee H; Sasikala AR; Kim CS; Park IK; Jeong YY
    Carbohydr Polym; 2015 Oct; 131():439-46. PubMed ID: 26256205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetically Enhanced Intracellular Uptake of Superparamagnetic Iron Oxide Nanoparticles for Antitumor Therapy.
    Choi J; Kim DI; Kim JY; Pané S; Nelson BJ; Chang YT; Choi H
    ACS Nano; 2023 Aug; 17(16):15857-15870. PubMed ID: 37477428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biotechnological approach to induce human fibroblast apoptosis using superparamagnetic iron oxide nanoparticles.
    Ferraz FS; López JL; Lacerda SMSN; Procópio MS; Figueiredo AFA; Martins EMN; Guimarães PPG; Ladeira LO; Kitten GT; Dias FF; Domingues RZ; Costa GMJ
    J Inorg Biochem; 2020 May; 206():111017. PubMed ID: 32120160
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Kim H; Im PW; Lee C; Hong H; Lee W; Koo C; Park SY; Im HJ; Paek SH; Piao Y
    RSC Adv; 2023 Jan; 13(5):2803-2810. PubMed ID: 36756446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Citrate- and Gold-Stabilized Superparamagnetic Iron Oxide Nanoparticles on Head and Neck Tumor Cell Lines during Combination Therapy with Ionizing Radiation.
    Schreiber C; Franzen T; Hildebrand L; Stein R; Friedrich B; Tietze R; Fietkau R; Distel LV
    Bioengineering (Basel); 2022 Dec; 9(12):. PubMed ID: 36551012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aminosilanized flower-structured superparamagnetic iron oxide nanoparticles coupled to
    Stanković A; Mihailović J; Mirković M; Radović M; Milanović Z; Ognjanović M; Janković D; Antić B; Mijović M; Vranješ-Đurić S; Prijović Ž
    Int J Pharm; 2020 Sep; 587():119628. PubMed ID: 32681867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Luteinizing hormone-releasing hormone targeted superparamagnetic gold nanoshells for a combination therapy of hyperthermia and controlled drug delivery.
    Mohammad F; Al-Lohedan HA
    Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():692-700. PubMed ID: 28482580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxyapatite as a Vehicle for the Selective Effect of Superparamagnetic Iron Oxide Nanoparticles against Human Glioblastoma Cells.
    Pernal S; Wu VM; Uskoković V
    ACS Appl Mater Interfaces; 2017 Nov; 9(45):39283-39302. PubMed ID: 29058880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superparamagnetic and highly bioactive SPIONS/bioactive glass nanocomposite and its potential application in magnetic hyperthermia.
    Borges R; Ferreira LM; Rettori C; Lourenço IM; Seabra AB; Müller FA; Ferraz EP; Marques MM; Miola M; Baino F; Mamani JB; Gamarra LF; Marchi J
    Mater Sci Eng C Mater Biol Appl; 2022 Apr; 135():112655. PubMed ID: 35577690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Progress in Iron Oxide Nanoparticles as Therapeutic Magnetic Agents for Cancer Treatment and Tissue Engineering.
    Nabavinia M; Beltran-Huarac J
    ACS Appl Bio Mater; 2020 Dec; 3(12):8172-8187. PubMed ID: 35019598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.
    Wahajuddin ; Arora S
    Int J Nanomedicine; 2012; 7():3445-71. PubMed ID: 22848170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immuno-hyperthermia effected by antibody-conjugated nanoparticles selectively targets and eradicates individual cancer cells.
    Kagawa T; Matsumi Y; Aono H; Ohara T; Tazawa H; Shigeyasu K; Yano S; Takeda S; Komatsu Y; Hoffman RM; Fujiwara T; Kishimoto H
    Cell Cycle; 2021 Jul; 20(13):1221-1230. PubMed ID: 34148497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: magnetic targeting.
    Mojica Pisciotti ML; Lima E; Vasquez Mansilla M; Tognoli VE; Troiani HE; Pasa AA; Creczynski-Pasa TB; Silva AH; Gurman P; Colombo L; Goya GF; Lamagna A; Zysler RD
    J Biomed Mater Res B Appl Biomater; 2014 May; 102(4):860-8. PubMed ID: 24458920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and Evaluation of Doxorubicin-Loaded PLA-PEG-FA Copolymer Containing Superparamagnetic Iron Oxide Nanoparticles (SPIONs) for Cancer Treatment: Combination Therapy with Hyperthermia and Chemotherapy.
    Khaledian M; Nourbakhsh MS; Saber R; Hashemzadeh H; Darvishi MH
    Int J Nanomedicine; 2020; 15():6167-6182. PubMed ID: 32922000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy.
    Zhi D; Yang T; Yang J; Fu S; Zhang S
    Acta Biomater; 2020 Jan; 102():13-34. PubMed ID: 31759124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface modified iron-oxide based engineered nanomaterials for hyperthermia therapy of cancer cells.
    Mehak ; Thummer RP; Pandey LM
    Biotechnol Genet Eng Rev; 2023 Jan; ():1-47. PubMed ID: 36710396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro evaluation of actively targetable superparamagnetic nanoparticles to the folate receptor positive cancer cells.
    Nasiri R; Hamzehalipour Almaki J; Idris AB; Abdul Majid FA; Nasiri M; Salouti M; Irfan M; Amini N; Marvibaigi M
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():1147-58. PubMed ID: 27612812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells.
    Kumar M; Singh G; Arora V; Mewar S; Sharma U; Jagannathan NR; Sapra S; Dinda AK; Kharbanda S; Singh H
    Int J Nanomedicine; 2012; 7():3503-16. PubMed ID: 22848174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect.
    Hayashi K; Ono K; Suzuki H; Sawada M; Moriya M; Sakamoto W; Yogo T
    ACS Appl Mater Interfaces; 2010 Jul; 2(7):1903-11. PubMed ID: 20568697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model.
    Rego GNA; Mamani JB; Souza TKF; Nucci MP; Silva HRD; Gamarra LF
    Einstein (Sao Paulo); 2019 Aug; 17(4):eAO4786. PubMed ID: 31390427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.